noom microdosing glp-1 introduces longevity-focused with at-home biomarker tracking Microdosing GLP-1 for Weight Loss

PMID: 19699913

General guidelines and dosing for patients with T2D: Initiate pramlintide at the 60 mcg dose taken immediately prior to major meals Titrate pramlintide to 120 mcg dose after 3 or more days with no clinically significant nausea Optimize insulin to achieve glycemic targets once the maintenance dose of pramlintide is reached and blood glucose concentrations are stable Practical Tips for Patients On Pramlintide Start With a Low Dose and Titrate Slowly Pramlintide can cause nausea, anorexia and vomiting, especially in T1D where a more gradual titration is required

The role of free radicals and antioxidants in reproduction

But the discomfort was well worth it

Topical application/formulation of probiotics: will it be a novel treatment approach for diabetic foot ulcer